Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

New Criteria for Accessory Pathway Localization From Surface ECG

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03875222
Recruitment Status : Unknown
Verified March 2019 by Haidy Yacoup Daoud Danial, Assiut University.
Recruitment status was:  Not yet recruiting
First Posted : March 14, 2019
Last Update Posted : March 19, 2019
Sponsor:
Information provided by (Responsible Party):
Haidy Yacoup Daoud Danial, Assiut University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
study for discovering new criteria for localization of site of accessory pathway from surface ECG

Condition or disease
Accessory Pathway

Detailed Description:
the study aims for discovering new criteria for percise localization of accessory pathway from surface ECG in referance to final flouroscopic ablation site
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Studying New Criteria for Prediction of Site of Accessory Pathway From Surface ECG
Estimated Study Start Date : April 2019
Estimated Primary Completion Date : April 2021
Estimated Study Completion Date : August 2021

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. percise localization of accessory pathway from surface ECG in referance to successful ablation site [ Time Frame: 2 years ]
    successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   10 Years to 90 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
any patient with manifest accessory pathway between 10 and 90 years of age undergoing EP maping and ablation.
Criteria

Inclusion Criteria:

  • any patient with manifest accessory pathway .

Exclusion Criteria:

  • multiple accessory pathways .previous ablation.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

No Contacts or Locations Provided
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Haidy Yacoup Daoud Danial, principle investigator, Assiut University
ClinicalTrials.gov Identifier: NCT03875222    
Other Study ID Numbers: Accessory pathway location
First Posted: March 14, 2019    Key Record Dates
Last Update Posted: March 19, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Pre-Excitation Syndromes
Accessory Atrioventricular Bundle
Pathological Conditions, Anatomical
Arrhythmias, Cardiac
 Heart Diseases
Cardiovascular Diseases
Cardiac Conduction System Disease